AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction

This study will assess the safety and efficacy of intracoronary artery administered autologous bone marrow derived stem cells in subjects post ST segment elevation myocardial infarction (STEMI). Efficacy will be assessed by evaluating and comparing the autologous stem cell treatment group to the control group via change in myocardial perfusion (RTSS) measured quantitatively by gated single photon emission computed tomography myocardial perfusion imaging (gated SPECT MPI) among other secondary endpoints measured by cardiac MRI in addition to clinical endpoints.

Principal Investigator

CONTACT INFORMATION

Primary Contact:
Tom Moss, MD
(818) 903-4036